← Back to headlines
Definium Therapeutics Stock Soars on Positive Drug Candidate Trial Results
Definium Therapeutics (DFTX) shares reached a new high following impressive trial results for its drug candidate, indicating positive progress in its clinical development.
23 Jun, 01:57 — 23 Jun, 01:57
Sources
Showing 1 of 1 sources
